Fidelity Investments’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,376,153
| Closed | -$2.13M | – | 5634 |
|
|
2022
Q4 | $2.13M | Sell |
12,376,153
-1,081,346
| -8% | -$186K | ﹤0.01% | 2357 |
|
|
2022
Q3 | $5.84M | Sell |
13,457,499
-71,426
| -0.5% | -$31K | ﹤0.01% | 2112 |
|
|
2022
Q2 | $11.5M | Buy |
13,528,925
+932
| +0% | +$793 | ﹤0.01% | 1906 |
|
|
2022
Q1 | $74.5M | Buy |
13,527,993
+48,127
| +0.4% | +$265K | 0.01% | 1205 |
|
|
2021
Q4 | $130M | Sell |
13,479,866
-47,627
| -0.4% | -$461K | 0.01% | 985 |
|
|
2021
Q3 | $242M | Hold |
13,527,493
| – | – | 0.02% | 724 |
|
|
2021
Q2 | $330M | Hold |
13,527,493
| – | – | 0.03% | 613 |
|
|
2021
Q1 | $358M | Buy |
13,527,493
+2,149,226
| +19% | +$57M | 0.03% | 550 |
|
|
2020
Q4 | $86.4M | Buy |
11,378,267
+1,150,742
| +11% | +$8.73M | 0.01% | 1097 |
|
|
2020
Q3 | $51.2M | Sell |
10,227,525
-214,370
| -2% | -$1.07M | 0.01% | 1179 |
|
|
2020
Q2 | $62.4M | Buy |
10,441,895
+459,724
| +5% | +$2.75M | 0.01% | 1073 |
|
|
2020
Q1 | $44.4M | Buy |
9,982,171
+814,879
| +9% | +$3.63M | 0.01% | 1077 |
|
|
2019
Q4 | $87.1M | Buy |
9,167,292
+1,349,662
| +17% | +$12.8M | 0.01% | 963 |
|
|
2019
Q3 | $61.4M | Buy |
7,817,630
+244,970
| +3% | +$1.92M | 0.01% | 1078 |
|
|
2019
Q2 | $119M | Buy |
7,572,660
+552,930
| +8% | +$8.7M | 0.01% | 847 |
|
|
2019
Q1 | $127M | Buy |
7,019,730
+573,662
| +9% | +$10.4M | 0.02% | 801 |
|
|
2018
Q4 | $101M | Buy |
6,446,068
+219,304
| +4% | +$3.43M | 0.01% | 846 |
|
|
2018
Q3 | $141M | Buy |
+6,226,764
| New | +$141M | 0.02% | 794 |
|